Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06096324 · ClinicalTrials.gov registry record · NA

Education and Employment Support for HIV Prevention in Young Adults (ENSPIRE)

A NA study of Utilization, Health Care and Condomless Sex, sponsored by University of North Carolina, Chapel Hill.

Recruiting
Registry status
NA
Development phase
500
Enrollment target
1
Study location

NCT06096324: Recruiting NA study of Utilization, Health Care and Condomless Sex, sponsored by University of North Carolina, Chapel Hill.

NCT06096324 is a NA study of Utilization, Health Care and Condomless Sex that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 500 participants, above the 243-participant average among 4 other Utilization, Health Care trials with a reported enrollment target (106% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06096324, a NA study of Utilization, Health Care and Condomless Sex, is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.

RECRUITING
Registry status
NA
Development phase
500 participants
Enrollment target
1
Study location

Study Summary

The study team will conduct a two-group study to examine the efficacy of implementing a combination intervention to improve economic stability and HIV preventive behaviors. The team will enroll approximately 500 young adults. Participants will be randomly assigned to one of two groups. The first group ("control") will receive text messages with information on job openings. The second group ("intervention") will receive text messages with information on job openings plus HIV prevention text messages, educational sessions on employment, income generation, and HIV prevention, economic resources, and mentoring.

Primary Outcome

The economic stability score of participants in each group in the past six months will be measured using a participant survey. The economic stability scale measures extent of economic stability and ranges from 0 to 64 with higher scores indicating a better outcome.

Interventions

  • BEHAVIORAL Job announcements plus HIV prevention text messages, educational sessions, economic resources, and mentoring.
  • BEHAVIORAL Job announcements

Study Locations (1)

Maryland

  • Johns Hopkins University - Baltimore

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2023-09-19
Est. Completion 2028-03-31
Phase NA

What NCT06096324 shows while recruiting

NCT06096324 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 243-participant average among 4 other Utilization, Health Care trials with a reported enrollment target (106% higher).

The record links to 3 conditions, with Utilization, Health Care appearing as the primary indexed condition, and to 2 interventions - of which Job announcements plus HIV prevention text messages, educational sessions, economic resources, and mentoring. is the first listed.

NCT06096324 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT06096324 about?

NCT06096324 is a clinical study titled "Education and Employment Support for HIV Prevention in Young Adults (ENSPIRE)". The study team will conduct a two-group study to examine the efficacy of implementing a combination intervention to improve economic stability and HIV preventive behaviors. The team will enroll approximately 500 young adults. Participants will be randomly assigned to one of two groups. The first gro...

What is the current status of trial NCT06096324?

This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2023-09-19. Estimated completion is 2028-03-31.

What conditions does trial NCT06096324 study?

This clinical trial studies the following conditions: Utilization, Health Care, Condomless Sex, Economic Hardship.

What interventions are being tested in trial NCT06096324?

The interventions under investigation include: Job announcements plus HIV prevention text messages, educational sessions, economic resources, and mentoring. (BEHAVIORAL), Job announcements (BEHAVIORAL).

Who is sponsoring clinical trial NCT06096324?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06096324 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Utilization, Health Care

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06096324, the US trial registry maintained by the National Library of Medicine. NCT06096324 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.